Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Scaffold-Hydrogel Synergy with OPC-Crosslinked dUECM and VEGF-Nanocomposite Hydrogel Achieves Dual "Structural-Vascular" Regeneration in Rats.

Created on 20 Oct 2026

Authors

Xinji Wang, Qin Gu, Yijia Zhang, Yujie Wu, Dedong Yu, Yingnan Xiao, Huizhe Chen, Xiehua Pan, Deli Zhuge, Yingzheng Zhao

Published in

Advanced healthcare materials. Pages e71863. Oct 19, 2026. Epub Oct 19, 2026.

Abstract

Absolute uterine factor infertility (AUFI) remains untreatable with current assisted reproduction techniques. Although decellularized uterine extracellular matrix (dUECM) holds promise for uterine reconstruction, its clinical translation is limited by rapid degradation and poor angiogenic capacity. Herein, a dual-component system was developed by combining oligomeric proanthocyanidin (OPC)-crosslinked dUECM with an injectable VEGF-loaded nanocomposite hydrogel. The OPC-dUECM scaffold (1 mg/mL OPC solution) restored native-like tensile strength, reduced collagenase-induced degradation to 52%, and facilitated cellular infiltration. The VEGF-EPL-HP nanocomposite hydrogel was fabricated by encapsulating VEGF (350 ng/mL) in ε-polylysine/heparin-poloxamer (EPL-HP) nanoparticles dispersed within a thermosensitive hydrogel. The hydrogel exhibited a gelation temperature of 23.2°C, provided sustained VEGF release over 7 days, and showed negligible hemolytic toxicity. In vitro, this hydrogel significantly enhanced the migration and tube formation of human umbilical vein endothelial cells. At 90 days post-surgery in a rat uterine defect model, the combined OPC-dUECM + VEGF-EPL-HP group achieved full endometrial and myometrial regeneration, accompanied by elevated microvessel density, attenuated inflammation, and negligible fibrotic lesions. Collectively, this study validated a synergistic scaffold-hydrogel platform enabling concurrent structural reconstruction and vascularization of the injured uterus, offering a clinically translatable strategy for AUFI patients.

PMID:
42897847
Bibliographic data and abstract were imported from PubMed on 20 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement